High materiality7/10
Goldman Sachs Upgrades Protagonist Therapeutics (PTGX) to Buy
Why it may matterVerify against the original reporting
buy
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
Goldman Sachs upgrade to Buy; target $186; current price $145.87; priceChangeSinceSignal +$6.33.
- Target $186; price $145.87; +$6.33 since signal; Goldman Sachs Buy
Key facts
- 01
Target: $186
- 02
Posted price: $145.87
- 03
Analyst firm: Goldman Sachs
- 04
Analyst: Richard Law
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.